Diomed (DIOM) 8-K Departure of Directors or Principal Officers

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported)

May 16, 2007

DIOMED HOLDINGS, INC.

Delaware (State or other jurisdiction of incorporation) 000-32045 (Commission File Number) 84-1480636 (IRS Employer Identification No.)

1 Dundee Park Andover, MA (Address of Principal Executive Offices)   01810 (Zip Code)

Registrant’s telephone number, including area code: (978-475-7771)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Effective May 17, 2007, the Registrant increased the annual base salary of Christopher Geberth, its Vice President of Finance, by $10,000 to $153,000.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Diomed Holdings, Inc.

(Registrant)

Date:  May 16, 2007

By:  /s/ DAVID B. SWANK

Name:  David B. Swank

Title:    Chief Financial Officer